Complexes of Streptavidin-Fused Antigens with Biotinylated Antibodies Targeting Receptors on Dendritic Cell Surface: A Novel Tool for Induction of Specific T-Cell Immune Responses

被引:6
|
作者
Stanek, Ondrej [1 ,2 ]
Linhartova, Irena [1 ]
Majlessi, Laleh [3 ,4 ]
Leclerc, Claude [3 ,4 ]
Sebo, Peter [1 ]
机构
[1] ASCR Vvi, Lab Mol Biol Bacterial Pathogens, Inst Microbiol, Prague 14220, Czech Republic
[2] Inst Chem Technol, CR-16628 Prague, Czech Republic
[3] Inst Pasteur, Unite Regulat Immunitaire & Vaccinol, F-75724 Paris, France
[4] INSERM, U1041, F-75015 Paris, France
关键词
Streptavidin; Antigen delivery; Biotinylated antibody; T-cell response; Dendritic cell; Receptor targeting; MYCOBACTERIUM-TUBERCULOSIS; CORE-STREPTAVIDIN; FUSION PROTEIN; IN-VIVO; ESAT-6-CFP-10; COMPLEX; PRESENTING CELLS; DEC-205; RECEPTOR; DRUG-DELIVERY; BONE-MARROW; VACCINATION;
D O I
10.1007/s12033-011-9459-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The choice of tools that enable efficient targeting of exogenous antigens (Ag) for processing and presentation by professional Ag-presenting cells (APC) remains limited. This represents, indeed, a bottleneck in development of vaccines inducing specific T-cell responses. Here, we describe a novel strategy of Ag delivery into APCs. The Ag of choice is fused to the N- or C-terminus of streptavidin (SA) and tetrameric Ag-SA or SA-Ag fusion proteins are produced in E. coli and purified by 2-Iminobiotin-Agarose affinity chromatography. Alternatively, Ag-SA proteins are purified from urea extracts of E. coli inclusion bodies and refolded in vitro into functional tetramers. Complexes with biotinylated antibodies targeting cell surface receptors are formed and used to deliver the Ags of choice for processing and presentation by APCs and induction of Ag-specific CD4(+) and CD8(+) T-cell responses in vitro and in vivo.
引用
收藏
页码:221 / 232
页数:12
相关论文
共 50 条
  • [41] CD83+ human dendritic cells transfected with tumor peptide cDNA by electroporation induce specific T-cell responses: A potential tool for gene immunotherapy
    Sabine Lohmann
    Katharina Galle
    Jürgen Knop
    Alexander H Enk
    Cancer Gene Therapy, 2000, 7 : 605 - 614
  • [42] CD83+ human dendritic cells transfected with tumor peptide cDNA by electroporation induce specific T-cell responses:: A potential tool for gene immunotherapy
    Lohmann, S
    Galle, K
    Knop, J
    Enk, AH
    CANCER GENE THERAPY, 2000, 7 (04) : 605 - 614
  • [43] Targeting cryptic epitope with modified antigen coupled to the surface of liposomes induces strong antitumor CD8 T-cell immune responses in vivo
    Horiuchi, Yutaka
    Takagi, Akira
    Uchida, Tetsuya
    Akatsuka, Toshitaka
    ONCOLOGY REPORTS, 2015, 34 (06) : 2827 - 2836
  • [45] Personalized ddPCR Mutation Assays Targeting Patient Specific ctDNA: A Tool to Monitor Treatment Responses to Mutation-Specific T-cell Transfer Immunotherapy in Epithelial Cancer Patients
    Xi, L.
    Chung, H.
    Ho, J.
    Pham, T. H.
    Zacharakis, N.
    Feldman, S. A.
    Robbins, P. F.
    Rosenberg, S. A.
    Raffeld, M.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2018, 20 (06): : 984 - 984
  • [46] Targeting a Mimotope Vaccine to Activating Fcγ Receptors Empowers Dendritic Cells to Prime Specific CD8+ T Cell Responses in Tumor-Bearing Mice
    Gil, Margaret
    Bieniasz, Magdalena
    Wierzbicki, Andrzej
    Bambach, Barbara J.
    Rokita, Hanna
    Kozbor, Danuta
    JOURNAL OF IMMUNOLOGY, 2009, 183 (10): : 6808 - 6818
  • [47] Vector-based delivery of tumor-associated antigens and T-cell co-stimulatory molecules in the induction of immune responses and anti-tumor immunity
    Hodge, JW
    Grosenbach, DW
    Schlom, J
    CANCER DETECTION AND PREVENTION, 2002, 26 (04): : 275 - 291
  • [48] Induction of human immunodeficiency virus (HIV)-specific CD8 T-cell responses by Listeria monocytogenes and a hyperattenuated Listeria strain engineered to express HIV antigens
    Friedman, RS
    Frankel, FR
    Xu, Z
    Lieberman, J
    JOURNAL OF VIROLOGY, 2000, 74 (21) : 9987 - 9993
  • [49] Induction of chronic lymphocytic leukemia (CLL)-specific CD4- and CD8-mediated T-cell responses using RNA-transfected dendritic cells
    Müller, MR
    Tsakou, G
    Grünebach, F
    Schmidt, SM
    Brossart, P
    BLOOD, 2004, 103 (05) : 1763 - 1769
  • [50] Induction of tumor-specific T-cell responses by vaccination with tumor lysate-loaded dendritic cells in colorectal cancer patients with carcinoembryonic-antigen positive tumors
    Tamir, Ayala
    Basaglia, Ernesto
    Kagahzian, Arash
    Jiao, Long
    Jensen, Steen
    Nicholls, Joanna
    Tate, Paul
    Stamp, Gordon
    Farzaneh, Farzin
    Harrison, Phillip
    Stauss, Hans
    George, Andrew J. T.
    Habib, Nagy
    Lechler, Robert I.
    Lombardi, Giovanna
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2007, 56 (12) : 2003 - 2016